M. Green, A. Gentles, R. Nair, J. Irish, S. Kihira et al., Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma, Blood, vol.121, issue.9, pp.1604-1615, 2013.
DOI : 10.1182/blood-2012-09-457283

M. Green, S. Kihira, C. Liu, R. Nair, R. Salari et al., Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation, Proceedings of the National Academy of Sciences, vol.19, issue.1, pp.1116-1125, 2015.
DOI : 10.1073/pnas.1002057107

R. Kridel, F. Chan, A. Mottok, M. Boyle, P. Farinha et al., Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study, PLOS Medicine, vol.116, issue.17, p.1002197, 2016.
DOI : 10.1371/journal.pmed.1002197.s034

H. Li, M. Kaminski, Y. Li, M. Yildiz, P. Ouillette et al., Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma, Blood, vol.123, issue.10, pp.1487-98, 2014.
DOI : 10.1182/blood-2013-05-500264

J. Okosun, C. Bödör, J. Wang, S. Araf, C. Yang et al., Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma, Nature Genetics, vol.61, issue.2, pp.176-81, 2014.
DOI : 10.1371/journal.pgen.1002691

J. Okosun, R. Wolfson, J. Wang, S. Araf, L. Wilkins et al., Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma, Nature Genetics, vol.4, issue.2, pp.183-191, 2016.
DOI : 10.1073/pnas.92.16.7297

L. Pasqualucci, H. Khiabanian, M. Fangazio, M. Vasishtha, M. Messina et al., Genetics of Follicular Lymphoma Transformation, Cell Reports, vol.6, issue.1, pp.130-170, 2014.
DOI : 10.1016/j.celrep.2013.12.027

M. Gerlinger, A. Rowan, S. Horswell, J. Larkin, D. Endesfelder et al., Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing, New England Journal of Medicine, vol.366, issue.10, pp.883-92, 2012.
DOI : 10.1056/NEJMoa1113205

A. Makohon-moore, M. Zhang, J. Reiter, I. Bozic, A. B. Kundu et al., Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer, Nature Genetics, vol.57, issue.3, pp.358-66, 2017.
DOI : 10.1038/ng.3312

A. Pastore, V. Jurinovic, R. Kridel, E. Hoster, A. Staiger et al., Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry, The Lancet Oncology, vol.16, issue.9, pp.1111-1133, 2015.
DOI : 10.1016/S1470-2045(15)00169-2

Y. Jiang, A. Ortega-molina, H. Geng, H. Ying, K. Hatzi et al., Inactivation Promotes the Development of HDAC3-Dependent Lymphomas, Cancer Discovery, vol.7, issue.1, pp.38-53, 2017.
DOI : 10.1158/2159-8290.CD-16-0975

J. Zhang, S. Vlasevska, V. Wells, S. Nataraj, A. Holmes et al., The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma, Cancer Discovery, vol.7, issue.3, pp.322-359, 2017.
DOI : 10.1158/2159-8290.CD-16-1417

A. Ortega-molina, I. Boss, A. Canela, H. Pan, Y. Jiang et al., The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development, Nature Medicine, vol.512, issue.10, pp.1199-208, 2015.
DOI : 10.1074/mcp.M114.046011

J. Zhang, D. Dominguez-sola, S. Hussein, J. Lee, A. Holmes et al., Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis, Nature Medicine, vol.57, issue.10, pp.1190-1198, 2015.
DOI : 10.1016/j.cell.2013.03.036

M. Jamal-hanjani, G. Wilson, N. Mcgranahan, N. Birkbak, T. Watkins et al., Tracking the Evolution of Non???Small-Cell Lung Cancer, New England Journal of Medicine, vol.376, issue.22, pp.2109-2130, 2017.
DOI : 10.1056/NEJMoa1616288

A. Roth, J. Khattra, D. Yap, A. Wan, E. Laks et al., PyClone: statistical inference of clonal population structure in cancer, Nature Methods, vol.11, issue.4, pp.396-398, 2014.
DOI : 10.1093/bioinformatics/btp698